• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾性骨营养不良的计算机定量骨闪烁显像观察

Observations on computerized quantitative bone scintigraphy in renal osteodystrophy.

作者信息

de Graaf P, Pauwels E K, Vos P H, Schicht I M, te Velde J, de Graeff J

出版信息

Eur J Nucl Med. 1984;9(9):419-25. doi: 10.1007/BF00295578.

DOI:10.1007/BF00295578
PMID:6437823
Abstract

Skeletal radiotracer (99mTc-HEDP) uptake was quantitated with and without the aid of a computer in 30 chronic dialysis patients with histologic evidence of renal osteodystrophy. Before scintigraphy, elevated soft-tissue activity due to the absence of renal radiotracer excretion was reduced by hemodialysis. The results were compared with those of a normal group and with the results of the biochemical and the bone morphometric studies of these patients. In all patients the radiotracer uptake was elevated, often markedly. In several patients with minimal histologic bone disease, however, soft-tissue activity could not be normalized by hemodialysis although its influence on the quantitative data could be further reduced (but not excluded) by computer evaluation of skeletal radiotracer uptake. Since the latter technique clearly distinguished the majority of the patients from the normals, it appears that computerized quantitative skeletal analysis is a potentially accurate scintigraphic method for detecting renal osteodystrophy. The significant relationship between skeletal radiotracer uptake, in particular at the bone biopsy site, and only the histologic features of increased bone turnover suggest that hyperparathyroidism is the major cause of this increased tracer uptake in renal osteodystrophy.

摘要

在30例有肾性骨营养不良组织学证据的慢性透析患者中,借助或不借助计算机对骨骼放射性示踪剂(99mTc - HEDP)摄取进行了定量分析。在闪烁扫描前,因肾脏放射性示踪剂排泄缺失导致的软组织活性升高通过血液透析得以降低。将结果与正常组以及这些患者的生化和骨形态计量学研究结果进行了比较。所有患者的放射性示踪剂摄取均升高,且常常显著升高。然而,在一些组织学骨病轻微的患者中,尽管通过计算机评估骨骼放射性示踪剂摄取可进一步降低(但不能排除)其对定量数据的影响,但血液透析无法使软组织活性恢复正常。由于后一种技术能明显区分大多数患者与正常人,因此计算机化定量骨骼分析似乎是检测肾性骨营养不良的一种潜在准确的闪烁扫描方法。骨骼放射性示踪剂摄取,尤其是在骨活检部位,与仅增加骨转换的组织学特征之间的显著关系表明,甲状旁腺功能亢进是肾性骨营养不良中这种示踪剂摄取增加的主要原因。

相似文献

1
Observations on computerized quantitative bone scintigraphy in renal osteodystrophy.肾性骨营养不良的计算机定量骨闪烁显像观察
Eur J Nucl Med. 1984;9(9):419-25. doi: 10.1007/BF00295578.
2
Bone scintigraphy in renal osteodystrophy.
J Nucl Med. 1978 Dec;19(12):1289-96.
3
Increased bone radiotracer uptake in renal osteodystrophy. Clinical evidence of hyperparathyroidism as the major cause.
Eur J Nucl Med. 1982;7(4):152-4. doi: 10.1007/BF00443921.
4
Quantitative bone scintigraphy in evaluating treatment of renal osteodystrophy.
Neth J Med. 1983;26(5):125-9.
5
Value of the 99mTc-methylene diphosphonate bone scan in renal osteodystrophy.99m锝-亚甲基二膦酸盐骨扫描在肾性骨营养不良中的价值。
Kidney Int. 1986 May;29(5):1058-65. doi: 10.1038/ki.1986.107.
6
Diphosphonates in the evaluation of metabolic bone disease.双膦酸盐在代谢性骨病评估中的应用
Clin Rheumatol. 1982 Mar;1(1):41-4. doi: 10.1007/BF02032475.
7
[Clinico-scintigraphic studies of bone disease (renal osteodystrophy) in patients on chronic hemodialysis (preliminary report)].[慢性血液透析患者骨病(肾性骨营养不良)的临床闪烁扫描研究(初步报告)]
Vutr Boles. 1988;27(2):107-12.
8
A trial of semiquantitative analysis of whole body bone scintigraphy in renal osteodystrophy.
Eur J Nucl Med. 1987;13(1):36-40. doi: 10.1007/BF00252644.
9
[Bone scintigraphy in evaluation of the effect of renal transplantation in patients with renal osteodystrophy].[骨闪烁显像在评估肾性骨营养不良患者肾移植效果中的应用]
Rinsho Hoshasen. 1989 Nov;34(12):1433-6.
10
[Histological and scintigraphic correlations in the diagnosis of uremic osteodystrophy].
Radiol Med. 1980 Oct;66(10):762-3.

引用本文的文献

1
(99m)Tc-MIBI Whole Body Scan: A Potentially Useful Technique for Evaluating Metabolic Bone Disease.(99m)锝-甲氧基异丁基异腈全身扫描:一种评估代谢性骨病的潜在有用技术。
World J Nucl Med. 2013 Jan;12(1):8-13. doi: 10.4103/1450-1147.113934.
2
A trial of semiquantitative analysis of whole body bone scintigraphy in renal osteodystrophy.
Eur J Nucl Med. 1987;13(1):36-40. doi: 10.1007/BF00252644.
3
The value of local 99mTc(Sn)-MDP bone to soft tissue uptake ratio in osteoporosis, before and during fluoride therapy.99mTc(锡)-亚甲基二膦酸盐骨软组织摄取比值在骨质疏松症患者氟化物治疗前后的价值

本文引用的文献

1
Bone scintigraphy in uremic pulmonary calcification.尿毒症性肺钙化的骨闪烁扫描。
J Nucl Med. 1979 Mar;20(3):201-6.
2
Increased bone radiotracer uptake in renal osteodystrophy. Clinical evidence of hyperparathyroidism as the major cause.
Eur J Nucl Med. 1982;7(4):152-4. doi: 10.1007/BF00443921.
3
Quantitative bone scintigraphy in evaluating treatment of renal osteodystrophy.
Neth J Med. 1983;26(5):125-9.
4
Eur J Nucl Med. 1990;16(3):157-60. doi: 10.1007/BF01146854.
4
Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failure.
Eur J Nucl Med. 1991;18(10):839-55. doi: 10.1007/BF00175066.
5
Tc-99m-HMDP bone uptake quantification and plasma osteocalcin levels in hemodialysis patients--a preliminary study.血液透析患者中锝-99m-羟亚甲基二膦酸盐骨摄取定量及血浆骨钙素水平——一项初步研究
Ann Nucl Med. 1992 Feb;6(1):9-12. doi: 10.1007/BF03164636.
The diagnosis of renal osteodystrophy: a comparison of Technetium-99m-pyrophosphate bone scintigraphy with other techniques.
Clin Nephrol. 1981 Jul;16(1):24-8.
5
[The value of scintimetry compared with histomorphology, parathormone assay, densitometry and radiology in renal osteopathy (author's transl)].[闪烁扫描术与组织形态学、甲状旁腺激素测定、骨密度测定及放射学在肾性骨病中的价值比较(作者译)]
Rofo. 1982 Jan;136(1):9-13. doi: 10.1055/s-2008-1055987.
6
Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy.对有继发性甲状旁腺功能亢进和肾性骨营养不良证据的慢性透析患者进行骨扫描。
Br J Radiol. 1975 Nov;48(575):878-84. doi: 10.1259/0007-1285-48-575-878.
7
Scintigraphy in uremic bone disease.尿毒症骨病的闪烁扫描术
Nephron. 1976;17(5):321-4. doi: 10.1159/000180737.
8
Scintigraphic skeletal changes in uremic patients on regular hemodialysis.接受定期血液透析的尿毒症患者的骨骼闪烁显像变化
Nephron. 1976;17(5):325-34. doi: 10.1159/000180738.
9
Iliac bone marrow trephine biopsy: some remarks on the technique.
Neth J Med. 1978;21(5):221-7.
10
The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.锝-99m二膦酸盐全身滞留显像在代谢性骨病诊断中的应用
J Nucl Med. 1978 Mar;19(3):270-5.